Literature DB >> 26422329

Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice.

Francesco Dentali1, Gianluca Di Micco2, Matteo Giorgi Pierfranceschi3, Gualberto Gussoni4, Giovanni Barillari5, Maria Amitrano6, Andrea Fontanella7, Corrado Lodigiani8, Anna Guida9, Adriana Visonà10, Manuel Monreal11, Pierpaolo Di Micco7.   

Abstract

BACKGROUND: Current guidelines recommend initial treatment with anticoagulants at home in patients with acute deep vein thrombosis (DVT) and in patients with low-risk pulmonary embolism (PE) with adequate home circumstances. However, most of the patients with acute venous thromboembolism (VTE) are currently hospitalized regardless of their risk of short-term complications. AIM OF THE STUDY: To assess the proportion of outpatients with acute VTE initially treated in hospitals, to assess the mean duration of hospitalization, and to identify predictors for in-hospital or home treatment.
METHODS: Data of Italian patients enrolled in the RIETE registry from January 2006 to December 2013 were included.
RESULTS: Altogether 766 PE and 1,452 isolated DVT were included. Among PE patients, mean PESI score was 84 points (SD 35), and 56% of patients had a low-risk PESI score (<85). In all, 53.7% of DVT and 17.0% of PE were entirely treated at home, and 38.2% of DVT patients and 19.9% of PE patients were hospitalized for ≤5 days. On multivariate analysis, low PESI score was not independently associated with the hospitalization of PE patients.
CONCLUSIONS: One in every two patients with DVT and five in every six with PE are still hospitalized.

Entities:  

Keywords:  Hospitalization; treatment; venous thromboembolism

Mesh:

Substances:

Year:  2015        PMID: 26422329     DOI: 10.3109/07853890.2015.1085127

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  10 in total

1.  Expression of microRNA-514a-5p and its biological function in experimental pulmonary thromboembolism.

Authors:  Yuanyuan Sun; Xingguo Zhang; Hua Gao; Mingjie Liu; Qi Cao; Xinyang Kang; Yusheng Wang; Ling Zhu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Is it reasonable to use a lower DOAC dose in some patients with VTE? NO.

Authors:  Francesco Dentali; Chiara Fantoni
Journal:  Intern Emerg Med       Date:  2017-06-27       Impact factor: 3.397

Review 3.  Risk stratification and management of acute pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis.

Authors:  Lisette F van Dam; Wilbert B van den Hout; Gargi Gautam; Charlotte E A Dronkers; Waleed Ghanima; Jostein Gleditsch; Anders von Heijne; Herman M A Hofstee; Marcel M C Hovens; Menno V Huisman; Stan Kolman; Albert T A Mairuhu; Mathilde Nijkeuter; Marcel A van de Ree; Cornelis J van Rooden; Robin E Westerbeek; Jan Westerink; Eli Westerlund; Lucia J M Kroft; Frederikus A Klok
Journal:  Blood Adv       Date:  2021-03-09

5.  Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis.

Authors:  Erin R Weeda; Sofia Butt
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-14       Impact factor: 2.389

Review 6.  Reducing the hospital burden associated with the treatment of pulmonary embolism.

Authors:  W Frank Peacock; Adam J Singer
Journal:  J Thromb Haemost       Date:  2019-04-01       Impact factor: 5.824

7.  Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE).

Authors:  Anthony J Weekes; Jaron D Raper; Kathryn Lupez; Alyssa M Thomas; Carly A Cox; Dasia Esener; Jeremy S Boyd; Jason T Nomura; Jillian Davison; Patrick M Ockerse; Stephen Leech; Jakea Johnson; Eric Abrams; Kathleen Murphy; Christopher Kelly; H James Norton
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

8.  Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis.

Authors:  Stefano Barco; Seyed Hamidreza Mahmoudpour; Benjamin Planquette; Olivier Sanchez; Stavros V Konstantinides; Guy Meyer
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983

9.  British Thoracic Society Quality Standards for outpatient management of pulmonary embolism.

Authors:  Robin Condliffe; Paul Albert; Raza Alikhan; Emma Gee; Daniel Horner; Laura Hunter; Phillip Jacobs; Rachel Limbrey; Michael Newnham; Wendy Preston; Sheena Patel; Laura-Jane Smith; Jay Suntharalingam
Journal:  BMJ Open Respir Res       Date:  2020-08

10.  Diagnosis and Treatment of Deep Vein Thrombosis in the Emergency Department: Results of an Italian Nominal Group Technique Study.

Authors:  Aldo Salvi; Cinzia Nitti; Andrea Fabbri; Paolo Groff; Enrico Giuseppe Ruggiero; Giancarlo Agnelli
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.